Edition:
India

Panacea Biotec Ltd (PNCA.BO)

PNCA.BO on Bombay Stock Exchange

140.00INR
20 Jun 2017
Change (% chg)

Rs-1.05 (-0.74%)
Prev Close
Rs141.05
Open
Rs142.65
Day's High
Rs143.00
Day's Low
Rs140.00
Volume
1,486
Avg. Vol
24,485
52-wk High
Rs178.30
52-wk Low
Rs103.00

Select another date:

Fri, Apr 21 2017

Narayana Hrudayalaya to buy NewRise Healthcare

Healthcare services provider Narayana Hrudayalaya Ltd said it would buy NewRise Healthcare Private Ltd from Panacea Biotec Ltd for an enterprise value of 1.80 billion rupees ($27.87 million).

India's Narayana Hrudayalaya to buy NewRise Healthcare

April 21 Indian healthcare services provider Narayana Hrudayalaya Ltd said it would buy NewRise Healthcare Private Ltd from Panacea Biotec Ltd for an enterprise value of 1.80 billion rupees ($27.87 million).

BRIEF-Panacea Biotec launches vaccine, Easysix, for 6 preventable diseases

* Says introduces fully liquid hexavalent combination vaccine easysixtm for six preventable diseases Source text for Eikon: Further company coverage:

BRIEF-Panacea Biotec says it has not signed any definitive agreement with Narayana Hrudayalaya

* Panacea Biotec clarifies on news item "Narayana Hrudayalaya in advanced talks to buy Panacea Biotec's Gurgaon hospital."

BRIEF-Panacea Biotec Dec qtr loss widens

* Dec quarter net loss 292.5 million rupees versus loss 173.8 million rupees year ago

BUZZ-India's Panacea Biotec hits over 1-year high; U.S. FDA okays generic migraine drug

** Drug maker Panacea Biotec Ltd surges as much as 17.4 pct to its highest since Dec 8, 2015

BRIEF-Panacea Biotec gets ANDA approval to market generic version of rizatriptan benzoate tablet

* Panacea Biotec Ltd says ANDA approval for us market and lta & award from un agencies for supply of pentavalent vaccine (easyfive-TT)

Select another date:

More From Around the Web